| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Joshua Chiappelli, Shuo Chen, Ann Hackman, L Elliot Hon. Evidence for differential opioid use disorder in schizophrenia in an addiction treatment population. Schizophrenia research. vol 194. 2018-11-13. PMID:28487076. |
in contrast, the schizophrenia sample had significantly higher proportions of individuals with problems with alcohol, cocaine, and cannabis relative to the treatment population. |
2018-11-13 |
2023-08-13 |
Not clear |
| Rachel A Rabin, Karolina Kozak, Konstantine K Zakzanis, Gary Remington, Cristiana Stefan, Alan J Budney, Tony P Georg. A method to achieve extended cannabis abstinence in cannabis dependent patients with schizophrenia and non-psychiatric controls. Schizophrenia research. vol 194. 2018-11-13. PMID:28506704. |
a method to achieve extended cannabis abstinence in cannabis dependent patients with schizophrenia and non-psychiatric controls. |
2018-11-13 |
2023-08-13 |
Not clear |
| Rachel A Rabin, Karolina Kozak, Konstantine K Zakzanis, Gary Remington, Cristiana Stefan, Alan J Budney, Tony P Georg. A method to achieve extended cannabis abstinence in cannabis dependent patients with schizophrenia and non-psychiatric controls. Schizophrenia research. vol 194. 2018-11-13. PMID:28506704. |
cannabis use disorders (cud) are common in schizophrenia (~25%) compared to the general population (~3%). |
2018-11-13 |
2023-08-13 |
Not clear |
| Rachel A Rabin, Karolina Kozak, Konstantine K Zakzanis, Gary Remington, Cristiana Stefan, Alan J Budney, Tony P Georg. A method to achieve extended cannabis abstinence in cannabis dependent patients with schizophrenia and non-psychiatric controls. Schizophrenia research. vol 194. 2018-11-13. PMID:28506704. |
therefore, we evaluated the utility of a sustained cannabis abstinence paradigm in patients with schizophrenia and non-psychiatric controls. |
2018-11-13 |
2023-08-13 |
Not clear |
| Susan Whitfield-Gabrieli, Adina S Fischer, Angela M Henricks, Jibran Y Khokhar, Robert M Roth, Mary F Brunette, Alan I Gree. Understanding marijuana's effects on functional connectivity of the default mode network in patients with schizophrenia and co-occurring cannabis use disorder: A pilot investigation. Schizophrenia research. vol 194. 2018-11-13. PMID:28823723. |
understanding marijuana's effects on functional connectivity of the default mode network in patients with schizophrenia and co-occurring cannabis use disorder: a pilot investigation. |
2018-11-13 |
2023-08-13 |
Not clear |
| Susan Whitfield-Gabrieli, Adina S Fischer, Angela M Henricks, Jibran Y Khokhar, Robert M Roth, Mary F Brunette, Alan I Gree. Understanding marijuana's effects on functional connectivity of the default mode network in patients with schizophrenia and co-occurring cannabis use disorder: A pilot investigation. Schizophrenia research. vol 194. 2018-11-13. PMID:28823723. |
nearly half of patients with schizophrenia (scz) have co-occurring cannabis use disorder (cud), which has been associated with decreased treatment efficacy, increased risk of psychotic relapse, and poor global functioning. |
2018-11-13 |
2023-08-13 |
Not clear |
| Britta Hah. The Potential of Cannabidiol Treatment for Cannabis Users With Recent-Onset Psychosis. Schizophrenia bulletin. vol 44. issue 1. 2018-11-05. PMID:29083450. |
a major factor associated with poor prognostic outcome after a first psychotic break is cannabis misuse, which is prevalent in schizophrenia and particularly common in individuals with recent-onset psychosis. |
2018-11-05 |
2023-08-13 |
Not clear |
| Patrick D Skosnik, Deepak C D'Souz. Opposing Effects of Cannabis Use on Electroencephalographic Measures of Auditory Repetition Suppression in Schizophrenia and Healthy Controls. Biological psychiatry. Cognitive neuroscience and neuroimaging. vol 2. issue 3. 2018-10-30. PMID:29528290. |
opposing effects of cannabis use on electroencephalographic measures of auditory repetition suppression in schizophrenia and healthy controls. |
2018-10-30 |
2023-08-13 |
Not clear |
| Chris Wagstaff, Hermine Graham, Derek Farrell, Michael Larkin, Lloyd Tatha. Perspectives of cannabis use in the life experience of men with schizophrenia. International journal of mental health nursing. vol 27. issue 3. 2018-10-29. PMID:29218823. |
perspectives of cannabis use in the life experience of men with schizophrenia. |
2018-10-29 |
2023-08-13 |
human |
| Chris Wagstaff, Hermine Graham, Derek Farrell, Michael Larkin, Lloyd Tatha. Perspectives of cannabis use in the life experience of men with schizophrenia. International journal of mental health nursing. vol 27. issue 3. 2018-10-29. PMID:29218823. |
the research question sought to understand, from the perspective of both service users and clinicians, cannabis use within the experience of people with schizophrenia. |
2018-10-29 |
2023-08-13 |
human |
| Chris Wagstaff, Hermine Graham, Derek Farrell, Michael Larkin, Lloyd Tatha. Perspectives of cannabis use in the life experience of men with schizophrenia. International journal of mental health nursing. vol 27. issue 3. 2018-10-29. PMID:29218823. |
this study provides greater depth to understanding cannabis use within the experience of people with a diagnosis of schizophrenia. |
2018-10-29 |
2023-08-13 |
human |
| Marieke Hiemstra, Stefanie A Nelemans, Susan Branje, Kristel R van Eijk, Jouke-Jan Hottenga, Christiaan H Vinkers, Pol van Lier, Wim Meeus, Marco P Bok. Genetic vulnerability to schizophrenia is associated with cannabis use patterns during adolescence. Drug and alcohol dependence. vol 190. 2018-10-23. PMID:30031300. |
genetic vulnerability to schizophrenia is associated with cannabis use patterns during adolescence. |
2018-10-23 |
2023-08-13 |
Not clear |
| Marieke Hiemstra, Stefanie A Nelemans, Susan Branje, Kristel R van Eijk, Jouke-Jan Hottenga, Christiaan H Vinkers, Pol van Lier, Wim Meeus, Marco P Bok. Genetic vulnerability to schizophrenia is associated with cannabis use patterns during adolescence. Drug and alcohol dependence. vol 190. 2018-10-23. PMID:30031300. |
the aim of the present longitudinal study was to investigate how a genetic predisposition to schizophrenia was associated with patterns of substance use (cannabis use, smoking, alcohol use) during adolescence (comparing ages 13-16 with 16-20 years). |
2018-10-23 |
2023-08-13 |
Not clear |
| Rachel A Rabin, Sarah S Dermody, Tony P Georg. Changes in tobacco consumption in cannabis dependent patients with schizophrenia versus non-psychiatric controls during 28-days of cannabis abstinence. Drug and alcohol dependence. vol 185. 2018-09-20. PMID:29459327. |
changes in tobacco consumption in cannabis dependent patients with schizophrenia versus non-psychiatric controls during 28-days of cannabis abstinence. |
2018-09-20 |
2023-08-13 |
Not clear |
| Rachel A Rabin, Sarah S Dermody, Tony P Georg. Changes in tobacco consumption in cannabis dependent patients with schizophrenia versus non-psychiatric controls during 28-days of cannabis abstinence. Drug and alcohol dependence. vol 185. 2018-09-20. PMID:29459327. |
tobacco and cannabis are highly co-morbid in the general population and in patients with schizophrenia. |
2018-09-20 |
2023-08-13 |
Not clear |
| Rachel A Rabin, Sarah S Dermody, Tony P Georg. Changes in tobacco consumption in cannabis dependent patients with schizophrenia versus non-psychiatric controls during 28-days of cannabis abstinence. Drug and alcohol dependence. vol 185. 2018-09-20. PMID:29459327. |
using a 28-day cannabis abstinence paradigm, we prospectively examined changes in tobacco consumption in patients with schizophrenia and controls with cannabis dependence and daily cigarette use. |
2018-09-20 |
2023-08-13 |
Not clear |
| Jasmina Mallet, Nicolas Ramoz, Yann Le Strat, Philip Gorwood, Caroline Dubertre. Heavy cannabis use prior psychosis in schizophrenia: clinical, cognitive and neurological evidences for a new endophenotype? European archives of psychiatry and clinical neuroscience. vol 267. issue 7. 2018-09-06. PMID:28190094. |
heavy cannabis use prior psychosis in schizophrenia: clinical, cognitive and neurological evidences for a new endophenotype? |
2018-09-06 |
2023-08-13 |
Not clear |
| Jasmina Mallet, Nicolas Ramoz, Yann Le Strat, Philip Gorwood, Caroline Dubertre. Heavy cannabis use prior psychosis in schizophrenia: clinical, cognitive and neurological evidences for a new endophenotype? European archives of psychiatry and clinical neuroscience. vol 267. issue 7. 2018-09-06. PMID:28190094. |
in a cross-sectional study, we consecutively included 61 patients with schizophrenia (34 reporting heavy cannabis use before the onset of psychosis and 27 not reporting such use), in the setting of a university hospital and a medical center. |
2018-09-06 |
2023-08-13 |
Not clear |
| M Aas, I Melle, F Bettella, S Djurovic, S Le Hellard, T Bjella, P A Ringen, T V Lagerberg, O B Smeland, I Agartz, O A Andreassen, M Tesl. Psychotic patients who used cannabis frequently before illness onset have higher genetic predisposition to schizophrenia than those who did not. Psychological medicine. vol 48. issue 1. 2018-08-06. PMID:28967348. |
psychotic patients who used cannabis frequently before illness onset have higher genetic predisposition to schizophrenia than those who did not. |
2018-08-06 |
2023-08-13 |
Not clear |
| Rami Guinguis, María Isabel Ruiz, Gabriel Rad. Is cannabidiol an effective treatment for schizophrenia? Medwave. vol 17. issue 7. 2018-05-28. PMID:28820868. |
is cannabidiol an effective treatment for schizophrenia? |
2018-05-28 |
2023-08-13 |
Not clear |